» Articles » PMID: 35859319

A Case of CIC-rearranged Sarcoma with CIC-LEUTX Gene Fusion in Spinal Cord

Overview
Journal Neuropathology
Specialties Neurology
Pathology
Date 2022 Jul 21
PMID 35859319
Authors
Affiliations
Soon will be listed here.
Abstract

A 16-year-old male was admitted to the hospital for weakness of both lower extremities. Magnetic resonance imaging revealed an intraspinal extramedullary subdural mass at the thoracic 9 level. Microscopically, the tumor cells were small to medium sized and round to ovoid in shape. They were distributed in diffuse sheets or showed nodular appearance. The nucleus of the tumor had mild-to-moderate atypia, with vesicular chromatin and prominent nucleoli. A smaller proportion of tumor cells demonstrated rhabdoid morphology. Focal myxoid stromal change was present, in which tumor cells exhibited spindle shapes. Approximately two mitoses were counted per 10 high-power fields. No necrosis was observed. The tumor cells were focal positive for CD99; multifocal positive for WT1; diffuse positive for nestin, synaptophysin, and D2-40; partial positive for GFAP; focal positive for desmin and SSTR2; and scattered positive for S-100 protein. The Ki-67 labeling index was approximately 20%. Genetic testing revealed CIC-LEUTX gene fusion. Considering the patient's history, clinical data, pathological findings and genetic findings, we rendered a rare tumor named CIC-rearranged sarcoma with CIC-LEUTX gene fusion.

Citing Articles

Capicua transcriptional repressor (CIC)-rearranged sarcoma harboring fusion with renal involvement: a rare case report.

Zhu J, Chen C, Li Y Transl Cancer Res. 2024; 13(10):5711-5718.

PMID: 39525005 PMC: 11543050. DOI: 10.21037/tcr-24-524.


CIC/ATXN1-rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series.

Tauziede-Espariat A, Ebrahimi A, Boddaert N, Pietsch T, Grajkowska W, Blau T Brain Pathol. 2024; 35(2):e13303.

PMID: 39442927 PMC: 11835441. DOI: 10.1111/bpa.13303.


Pediatric central nervous system tumor with CIC::LEUTX fusion: a diagnostic challenge.

Hou Y, Du Y, Zhang X, Zhao X, Xian X, Yuan L Acta Neuropathol Commun. 2024; 12(1):106.

PMID: 38926750 PMC: 11210039. DOI: 10.1186/s40478-024-01824-w.


Molecular and therapeutic advancements in Capicua ()-rearranged sarcoma.

Kriska M Ponce R, Luck C, Okimoto R Front Cell Dev Biol. 2024; 12:1416697.

PMID: 38882060 PMC: 11176417. DOI: 10.3389/fcell.2024.1416697.


Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion.

Andreiuolo F, Ferrone C, Rajan S, Perry A, Guney E, Cham E Acta Neuropathol Commun. 2024; 12(1):42.

PMID: 38500181 PMC: 10946093. DOI: 10.1186/s40478-024-01746-7.


References
1.
Sturm D, Orr B, Toprak U, Hovestadt V, Jones D, Capper D . New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016; 164(5):1060-1072. PMC: 5139621. DOI: 10.1016/j.cell.2016.01.015. View

2.
Choi E, Thomas D, McHugh J, Patel R, Roulston D, Schuetze S . Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology. Am J Surg Pathol. 2013; 37(9):1379-86. DOI: 10.1097/PAS.0b013e318297a57d. View

3.
Yoshimoto T, Tanaka M, Homme M, Yamazaki Y, Takazawa Y, Antonescu C . Induces Small Round Cell Sarcomas Distinct from Ewing Sarcoma. Cancer Res. 2017; 77(11):2927-2937. PMC: 5488331. DOI: 10.1158/0008-5472.CAN-16-3351. View

4.
Barresi S, Giovannoni I, Rossi S, Stracuzzi A, Quacquarini D, Cafferata B . A novel BRD4-LEUTX fusion in a pediatric sarcoma with epithelioid morphology and diffuse S100 expression. Genes Chromosomes Cancer. 2021; 60(9):647-652. DOI: 10.1002/gcc.22974. View

5.
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F . Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017; 7(1):4712. PMC: 5498486. DOI: 10.1038/s41598-017-04967-0. View